Board MeetingBoard Meeting
Hindustan Biosciences' board approved Q1 financial results, reporting a net loss of ₹0.11 Cr for the quarter.
Hindustan Bio Sciences Ltd532041 · Filed with the exchange
The 34th Annual General Meeting (AGM) is scheduled for September 30, 2026, to review the FY26 reports.
No comments yet. Be the first.